Stakeholder/Committee/Special Group Reporting and Approval Process

Identifying all the stakeholders and defining who needs to buy in and be aware of your efforts is important to increase the likelihood of early adoption, to give you legal protection for information you uncover, and to plan educational efforts. Typically, these groups include representation from:

1. Pharmacy and therapeutics committee
2. Pharmacists
3. Nursing groups (including leadership bodies, diabetes clinical specialists, and nursing education department members)
4. Endocrinologists
5. Hospitalists
6. Other internists
7. Critical care physicians
8. Orthopedics, surgery, trauma, and anesthesiology leaders
9. Diabetes educators (RN or RD-certified diabetes educators)
10. Patient safety committee
11. Or perioperative committees
12. Chief residents and/or residency program directors
13. Unit clerks/secretaries
14. Departmental committees
15. Nutritionist/dieticians
16. Lab
17. Biomedical, medical records, and CPOE expertise (if CPOE available)
18. Hospital informatics
19. Forms committee
20. Patients
21. Performance improvement/QI staff

Each hospital team must decide who will be the key core members essential for the development and implementation of the team initiative. Other persons whose input will be required periodically may serve as ad hoc glycemic control team members, for example, representatives from billing/coding services and finance.

TASK A    Identify key stakeholders, committees, and special groups that need to be aware of your efforts to improve glycemic control and reduce
                hypoglycemia.
TASK B    Clarify the reporting structure and approval process for your order sets, interventions, and resource approval.

Download the Task Sheet